Charles Bombardier noted that the rate of spontaneous remission could minimize the differences between experimental and control groups. This problem makes it difficult to determine the appropriate time to schedule outcome assessments and booster interventions.
Charles Bombardier noted that the rate of spontaneous remission could minimize the differences between experimental and control groups. Making it difficult to determine time to schedule outcome.